IGF1R as a Potential Pharmacological Target in Allergic Asthma.
Elvira Alfaro-ArnedoIcíar P LópezSergio Piñeiro-HermidaÁlvaro C UceroFrancisco-Javier Gonzalez-BarcalaFrancisco J SalgadoJosé G PichelPublished in: Biomedicines (2021)
Our results demonstrate that IGF1R could be considered a potential pharmacological target in murine HDM-induced asthma and a candidate biomarker in allergic asthma.